Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-08-05 00:00:00 ET · period of report 2024-08-01 · accession 0001649094-24-000044 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2024-08-05 | 2024-08-01 | PCVX | Wassil Jim | COO | S - Sale | $78.84 | -3,000 | 207.5K | -1% | -$236.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-01 | S | D | 2,977 | $78.84 | 207,526 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $78.28 to $79.23. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-08-01 | S | D | 23 | $79.47 | 207,503 | D | — | — |